Action Asterias Biotherapeutics, Inc. - AST

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

0,945

Prix Achat

Prix Vente

Volume échangé

0,00

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

0,945

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Asterias Provides Top Line 12 Month Data Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury

FREMONT, Calif., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat...

BioTime Announces Management Changes Concurrent With Participation at 2019 J.P. Morgan Healthcare Conference and 2019 Biotech...

ALAMEDA, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) -- BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced the appointment...

Asterias Biotherapeutics Announces Fourth Patient Dosed in First-in-Human Clinical Study of Immunotherapy VAC2 in Non-Small C...

FREMONT, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cellular immunotherapies to treat cancer...

FDA Accepts Asterias Biotherapeutics’ Request to Meet and Discuss Next Phase of Development for OPC1 Spinal Cord Injury Cli...

FREMONT, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

AST - Frequently Asked Questions (FAQ)

What is the current Asterias Biotherapeutics, Inc. share price?

The current share price of Asterias Biotherapeutics, Inc. is US$ 0,945

What is the 1 year trading range for Asterias Biotherapeutics, Inc. share price?

Asterias Biotherapeutics, Inc. has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
CHROChannel Therapeutics Corporation	US$ 1,90 (97,92%)	14,26M
GPUSHyperscale Data Inc	US$ 4,60 (22,99%)	215,83k
VINEFresh Vine Wine Inc	US$ 0,6899 (22,98%)	376,38k
RHERegional Health Properties Inc	US$ 2,40 (18,81%)	225,06k
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 13,245 (16,80%)	62,44M
FOXOFOXO Technologies Inc	US$ 0,2295 (-27,14%)	11,33M
OSTXOS Therapies Incorporated	US$ 3,03 (-26,46%)	1,63M
AEONAEON Biopharma Inc	US$ 0,1401 (-18,02%)	29,84M
MSTZT Rex 2X Inverse MSTR Daily Target ETF	US$ 12,56 (-16,32%)	26,29M
BOILProShares Ultra Bloomberg Natural Gas New	US$ 67,43 (-14,52%)	3,87M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 32,49 (8,34%)	69,67M
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 13,245 (16,80%)	62,42M
FXIiShares China Large Cap	US$ 30,40 (1,91%)	59,69M
SPYSPDR S&P 500	US$ 597,58 (1,00%)	57,16M
SOXSDirexion Daily Semiconductor Bear 3X Shares New	US$ 18,33 (-8,03%)	53,83M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Asterias Biotherapeutics Common Series A (AST)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

AST Dernières nouvelles

Asterias Provides Top Line 12 Month Data Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury

BioTime Announces Management Changes Concurrent With Participation at 2019 J.P. Morgan Healthcare Conference and 2019 Biotech...

Asterias Biotherapeutics Announces Fourth Patient Dosed in First-in-Human Clinical Study of Immunotherapy VAC2 in Non-Small C...

Asterias Biotherapeutics Reports Third Quarter Results

BioTime and Asterias Biotherapeutics Enter Into Definitive Merger Agreement to Create Leading Cell Therapy Company

BioTime Reports Third Quarter 2018 Financial Results and Provides Business Update

Asterias Biotherapeutics to Report Third Quarter 2018 Results on November 12, 2018

Asterias Biotherapeutics Announces Positive Outcome from Data Review from OPC1 Spinal Cord Injury Study

Asterias Biotherapeutics Announces Facilities and IP License Option Agreements

FDA Accepts Asterias Biotherapeutics’ Request to Meet and Discuss Next Phase of Development for OPC1 Spinal Cord Injury Cli...

AST - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Asterias Biotherapeutics Common Series A (AST) Cours

Asterias Biotherapeutics Common Series A (AST)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

AST Dernières nouvelles

AST - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE